Lectin binding and effects in culture on human cancer and non-cancer cell lines: examination of issues of interest in drug design strategies.

Lectin binding and effects in culture on human cancer and non-cancer cell lines: examination of issues of interest in drug design strategies. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Lectin binding and effects in culture on human cancer and non-cancer cell lines: examination of issues of interest in drug design strategies. Abstract Text:

Karineh Petrossian,Lisa R Banner,Steven B Oppenheimer,

By using a non-cancer and a cancer cell line originally from the same tissue (colon), coupled with testing lectins for cell binding and for their effects on these cell lines in culture, this study describes a simple multi-parameter approach that has revealed some interesting results that could be useful in drug development strategies. Two human cell lines, CCL-220/Colo320DM (human colon cancer cells, tumorigenic in nude mice) and CRL-1459/CCD-18Co (non-malignant human colon cells) were tested for their ability to bind to agarose microbeads derivatized with two lectins, peanut agglutinin (Arachis hypogaea agglutinin, PNA) and Dolichos biflorus agglutinin (DBA), and the effects of these lectins were assessed in culture using the MTT assay. Both cell lines bound to DBA-derivatized microbeads, and binding was inhibited by N-acetyl-D-galactosamine, but not by L-fucose. Neither cell line bound to PNA-derivatized microbeads. Despite the lack of lectin binding using the rapid microbead method, PNA was mitogenic in culture at some time points and its mitogenic effect displayed a reverse-dose response. This was also seen with effects of DBA on cells in culture. While this is a simple study, the results were statistically highly significant and suggest that: (1) agents may not need to bind strongly to cells to exert biological effects, (2) cell line pairs derived from diseased and non-diseased tissue can provide useful comparative data on potential drug effects and (3) very low concentrations of potential drugs might be initially tested experimentally because reverse-dose responses should be considered.

Lectin binding and effects in culture on human cancer and non-cancer cell lines: examination of issues of interest in drug design strategies. Publishing Authors By Initials

K Petrossian,LR Banner,SB Oppenheimer,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Lectin binding and effects in culture on human cancer and non-cancer cell lines: examination of issues of interest in drug design strategies. Journal Published:

PUBLICATION TYPE: Research Support, Non-U.S. Gov

Journal: Acta histochemica

VOLUME: 109

Page Numbers: 491-500

Journal Abbreviation: Acta Histochem.

ISSN: 0065-1281

DAY: 16

MONTH: 08

YEAR: 2007

Lectin binding and effects in culture on human cancer and non-cancer cell lines: examination of issues of interest in drug design strategies. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 370320

Lectin binding and effects in culture on human cancer and non-cancer cell lines: examination of issues of interest in drug design strategies. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Lectin binding and effects in culture on human cancer and non-cancer cell lines: examination of issues of interest in drug design strategies. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Lectin binding and effects in culture on human cancer and non-cancer cell lines: examination of issues of interest in drug design strategies.

AFFILIATION: Department of Biology and Center for Cancer and Developmental Biology, California State University Northridge, 18111 Nordhoff St. Northridge, CA 91330-8303, USA.

Country: Germany

AGENCY: United States PHS

GRANT: S0648680

ACRONYM:

MEDLINETA: Acta Histochem

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Lectin binding and effects in culture on human cancer and non-cancer cell lines: examination of issues of interest in drug design strategies Related Publications

• A magnetic ion source.
• Alcohol and drug misuse among women--an overview.
• Alteration of rabbit marrow fat in anemia from acetylphenylhydrazine.
• An integrated maternity, child health, and handicapped children's program.
• Arterial air embolism.
• Association of leukocyte count with progression of aortic atheroma in stroke/transient ischemic attack patients.
• Business and AIDS in South Africa.
• Calculous disease of the kidney and urinary tract.
• Content analysis of helping group interactions: toward a developmental perspective.
• Cyclodextrin, a probe for studying adhesive interactions.
• Effects of Fluency on Psychological Distance and Mental Construal (or Why New York Is a Large City, but New York Is a Civilized Jungle).
• Exogenous hyalin and sea urchin gastrulation, Part II: hyalin, an interspecies cell adhesion molecule.
• Hypernephroma in a horseshoe kidney.
• Immediate cardiovascular and respiratory adjustments to pneumonectomy.
• Iron and infection: the clinical evidence.
• Lectin binding and effects in culture on human cancer and non-cancer cell lines: examination of issues of interest in drug design strategies.
• Measurements of heart output by electro-kymography.
• Microplate assay for quantifying developmental morphologies: effects of exogenous hyalin on sea urchin gastrulation.
• Plus ca change ...
• Profiling risk: the emergence of coronary heart disease epidemiology in the United States (1947-70).
• Proton MR spectroscopy in acute middle cerebral artery stroke.
• Scale-ups, scarcity, and selections: the experience of doctors in South Africa.
• Sclerosing cholangitis: sonographic demonstration of bile duct wall thickening.
• Speakers gaze at objects while preparing intentionally inaccurate labels for them.
• Starling's law and X-ray density changes of heart shadow.
• The effect of intravenous procaine on the heart.
• The structure of the mind.
• [Not Available.]
• [Not Available.]
• [Post-renal transplantatation humoral acute rejection or anti-HLA antibodies-mediated acute rejection]